Peptris Overview

  • Year Founded
  • 2019

Year Founded

  • Status
  • Private

  • Employees
  • 10

Employees

  • Latest Deal Type
  • Project Financing

  • Latest Deal Amount
  • $8.98M

  • Investors
  • 10

Peptris General Information

Description

Developer of a drug-discovery platform designed to improve the efficiency of identifying therapeutic compounds. The company's platform uses artificial intelligence and generative models to create optimized molecular structures and reduce reliance on laboratory experiments, enabling pharmaceutical organizations to accelerate research while lowering costs.

Contact Information

Website
www.peptris.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • Center for Cellular and Molecular Platforms (C-CAMP)
  • NCBS-TIFR Campus, GKVK, Bellary Road
  • Bangalore, Karnataka 560065
  • India
+91 099452
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Corporate Office
  • Center for Cellular and Molecular Platforms (C-CAMP)
  • NCBS-TIFR Campus, GKVK, Bellary Road
  • Bangalore, Karnataka 560065
  • India
+91 099452

Peptris Timeline

2023202420252026
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Peptris Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
8. Project Financing 12-Oct-2026 $8.98M Completed Pre-Clinical Trials
7. Later Stage VC (Series A) 18-Feb-2026 Completed Pre-Clinical Trials
6. Accelerator/Incubator Completed Pre-Clinical Trials
5. Early Stage VC 19-Dec-2023 Completed Pre-Clinical Trials
4. Accelerator/Incubator 01-Jan-2022 Completed Startup
3. Seed Round 02-Nov-2021 Completed Startup
2. Accelerator/Incubator Completed Startup
1. Accelerator/Incubator Completed Startup
To view Peptris’s complete valuation and funding history, request access »

Peptris Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Pre-Seed CCPS
CCPS
Series Seed A Shares 16,862 $null $18 $18 1x $18 11.5%
To view Peptris’s complete cap table history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Peptris Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of a drug-discovery platform designed to improve the efficiency of identifying therapeutic compounds. The comp
Drug Discovery
Bangalore, India
10 As of 2026

Bengaluru, India
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Peptris Competitors (1)

One of Peptris’s competitors is ImmunitoAI, a Venture Capital-Backed company based in Bengaluru, India.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
ImmunitoAI Venture Capital-Backed Bengaluru, India
You’re viewing 1 of 1 competitors. Get the full list »

Peptris Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Peptris Investors (10)

Investor Name Investor Type Holding Investor Since Participating Rounds
BYT Capital Venture Capital Minority
Indian Angel Network Angel Group Minority
Inflection Point Ventures (India) Angel Group Minority
Rainmatter Capital Corporate Venture Capital Minority
Tenacity Ventures Growth/Expansion Minority
You’re viewing 5 of 10 investors. Get the full list »

Peptris FAQs

  • When was Peptris founded?

    Peptris was founded in 2019.

  • Where is Peptris headquartered?

    Peptris is headquartered in Bangalore, India.

  • What is the size of Peptris?

    Peptris has 10 total employees.

  • What industry is Peptris in?

    Peptris’s primary industry is Drug Discovery.

  • Is Peptris a private or public company?

    Peptris is a Private company.

  • What is Peptris’s current revenue?

    The current revenue for Peptris is .

  • How much funding has Peptris raised over time?

    Peptris has raised $18M.

  • Who are Peptris’s investors?

    BYT Capital, Indian Angel Network, Inflection Point Ventures (India), Rainmatter Capital, and Tenacity Ventures are 5 of 10 investors who have invested in Peptris.

  • Who are Peptris’s competitors?

    ImmunitoAI is a competitor of Peptris.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process